Evidence map›Paper›PMID 28280930›Full record

ArticleMammalian genome : official journal of the International Mammalian Genome Society2017

CRISPRtools: a flexible computational platform for performing CRISPR/Cas9 experiments in the mouse.

Kevin A Peterson, Glen L Beane, Leslie O Goodwin, Peter M Kutny, Laura G Reinholdt, Stephen A Murray

Abstract read
In one paragraph

Article in Mammalian genome : official journal of the International Mammalian Genome Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kevin A PetersonThe Jackson Laboratory, 600 Main St., Bar Harbor, ME, 04609, USA.
Glen L BeaneThe Jackson Laboratory, 600 Main St., Bar Harbor, ME, 04609, USA.
Leslie O GoodwinThe Jackson Laboratory, 600 Main St., Bar Harbor, ME, 04609, USA.
Peter M KutnyThe Jackson Laboratory, 600 Main St., Bar Harbor, ME, 04609, USA.
Laura G ReinholdtThe Jackson Laboratory, 600 Main St., Bar Harbor, ME, 04609, USA.ORCID http://orcid.org/0000-0002-0594-1702
Stephen A MurrayThe Jackson Laboratory, 600 Main St., Bar Harbor, ME, 04609, USA. Steve.Murray@jax.org.

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI OLGA ANCZUKOW-CAMARDA · 1985 to 2026
$61.9M
The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)UM1OD023222 · OD · JACKSON LABORATORY · PI ROBERT E BRAUN, Stephen A Murray · 2016 to 2026
$47.2M
The Mutant Mouse Resource and Research Center at The Jackson LaboratoryU42OD010921 · OD · JACKSON LABORATORY · PI Cathleen M Lutz · 2012 to 2026
$21.4M
High Throughput Production and Cryopreservation of Knockout MiceU42OD011185 · OD · JACKSON LABORATORY · PI MURRAY, STEPHEN A, TAFT, ROBERT A · 2012 to 2015
$17.9M
Mouse Mutant ResourceP40OD010972 · OD · JACKSON LABORATORY · PI BERGSTROM, DAVID ERIC, REINHOLDT, LAURA G · 2012 to 2015
$3.4M
Program ARISE: African mental health Researchers InSpired and EquippedD71TW011185 · FIC · UNIVERSITY OF CAPE TOWN · PI KAGEE, SHAHEEN ASHRAF, SORSDAHL, KATHERINE · 2019 to 2019
$50k
NCI NIH HHS P30 CA034196NIH HHS P40 OD010972NIH HHS U42 OD010921NIH HHS U42 OD011185NIH HHS UM1 OD023222NIH Office of the Director OD010972NIH Office of the Director OD011185NIH Office of the Director OD023222
6 · The paper itself

Abstract

Genome editing using the CRISPR/Cas9 RNA-guided endonuclease system has rapidly become a driving force for discovery in modern biomedical research. This simple yet elegant system has been widely used to generate both loss-of-function alleles and precision knock-in mutations using single-stranded donor oligonucleotides. Our CRISPRtools platform supports both of these applications in order to facilitate the use of CRISPR/Cas9. While there are several tools that facilitate CRISPR/Cas9 design and screen for potential off-target sites, the process is typically performed sequentially on single genes, limiting scalability for large-scale programs. Here, the design principle underlying gene ablation is based upon using paired guides flanking a critical region/exon of interest to create deletions. Guide pairs are rank ordered based upon published efficiency scores and off-target analyses, and reported in a concise format for downstream implementation. The exon deletion strategy simplifies characterization of founder animals and is the strategy employed for the majority of knockouts in the mouse. In proof-of-principle experiments, the effectiveness of this approach is demonstrated using microinjection and electroporation to introduce CRISPR/Cas9 components into mouse zygotes to delete critical exons.

Indexed as

CRISPR-Cas SystemsGene EditingSoftwareAnimalsComputational BiologyExonsGenotyping TechniquesMiceMice, TransgenicMicroinjectionsNonsense Mediated mRNA DecayRNA, Guide, CRISPR-Cas SystemsSequence DeletionWeb BrowserWorkflowZygoteRNA, Guide, CRISPR-Cas SystemsCas9 ProteinEfficiency ScoreExon DeletionGenome EditingNonsense Mediate Decay

Identifiers

PMID28280930
PMCPMC5591755

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.